You have 9 free searches left this month | for more free features.

Prolactinoma

Showing 1 - 25 of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Exercise Capacity and Physical Activity Level in Prolactinoma

Completed
  • Prolactinoma
    • Ankara, Turkey
      Hacettepe University
    Oct 29, 2022

    Pituitary Tumors and Related Hypothalmic Disorders

    Recruiting
    • Panhypopituitarism
    • +3 more
    • MRI
    • Tissue specimen collection
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Validation of a Quality of Life Metric "Prolac-10"

    Recruiting
    • Prolactinoma
    • +4 more
      • Columbus, Ohio
        Ohio State University
      Jun 20, 2021

      Hyperprolactinemia, Prolactinoma Trial in New York (Ropinirole)

      Completed
      • Hyperprolactinemia
      • Prolactinoma
      • New York, New York
        Columbia University Medical Center
      Jul 9, 2021

      Prolactinoma, Prolactin-Producing Pituitary Tumor Trial in Amsterdam-Zuidoost, Delft, Leiden (Endoscopic trans-sphenoidal

      Recruiting
      • Prolactinoma
      • Prolactin-Producing Pituitary Tumor
      • Endoscopic trans-sphenoidal adenoma resection
      • Dopamine Agonists
      • Amsterdam-Zuidoost, Noord-Holland, Netherlands
      • +2 more
      Jul 17, 2020

      Pituitary Adenoma, Prolactinoma, Pituitary Tumor Trial in Seoul (Cabergoline)

      Recruiting
      • Pituitary Adenoma
      • +3 more
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Mar 17, 2020

      Seoul National University Pituitary Disease Cohort Study

      Recruiting
      • Pituitary Disease
      • +7 more
      • Dynamic hormone study and Magnetic resonance imaging
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Mar 17, 2020

      Pituitary Adenomas, Prolactinomas Trial in Los Angeles, Baltimore, Boston (Lapatinib)

      Completed
      • Pituitary Adenomas
      • Prolactinomas
      • Los Angeles, California
      • +2 more
      Jan 13, 2020

      Long Term Outcome Study in Patients With Pituitary Disorders

      Active, not recruiting
      • Pituitary Diseases
      • Pituitary Neoplasms
        • (no location specified)
        Jan 30, 2023

        Prolactinoma Trial (Surgery, Drug treatment)

        Unknown status
        • Prolactinoma
        • Surgery
        • Drug treatment
        • (no location specified)
        Nov 19, 2018

        Genetics of Endocrine Tumours - Familial Isolated Pituitary

        Recruiting
        • Acromegaly
        • +5 more
          • London, United Kingdom
          • +1 more
          Oct 17, 2022

          Craniopharyngioma, Obesity Trial in Oldenburg

          Recruiting
          • Craniopharyngioma
          • Obesity
            • Oldenburg, Niedersachsen, Germany
              Klinikum Oldenburg
            Mar 29, 2022

            Pituitary Adenoma Trial in London (Intraoperative ultrasound)

            Recruiting
            • Pituitary Adenoma
            • Intraoperative ultrasound
            • London, United Kingdom
              National Hospital for Neurology and Neurosurgery
            Apr 26, 2021

            Resistance, Disease, Prolactinoma Trial in China (HCQ/CQ and CAB combined treatment)

            Unknown status
            • Resistance, Disease
            • Prolactinoma
            • HCQ/CQ and CAB combined treatment
            • Beijing, Beijing, China
            • +8 more
            Oct 14, 2018

            Rhinological Outcomes in Endonasal Pituitary Surgery

            Completed
            • Pituitary Neoplasm
            • +4 more
              • Phoenix, Arizona
              • +3 more
              Aug 21, 2018

              Pituitary Tumours: Prevalence of Associated Neoplasia

              Recruiting
              • Pituitary Tumor
              • +4 more
              • Registration of familial forms and associated neoplasia
              • Pozzilli, IS, Italy
                Neuromed
              Aug 31, 2021

              Prolactinoma Trial in Guangzhou (transsphenoidal surgery treatment, dopamine agonist treatment)

              Recruiting
              • Prolactinoma
              • transsphenoidal surgery treatment
              • dopamine agonist treatment
              • Guangzhou, China
                Sun Yat-sen 5010 program
              Nov 20, 2017

              Type 1 Diabetes Trial in Aurora (Bromocriptine, Placebo)

              Completed
              • Type 1 Diabetes
              • Aurora, Colorado
                University of Colorado-Denver, Anshutz Medical Campus
              Aug 16, 2021

              Overall and Disease Specific Survival in Confirmed MEN1 With or

              Active, not recruiting
              • Genetic Mutation
              • MEN1
              • Chart Review
              • Questionnaire
              • Houston, Texas
                University of Texas MD Anderson Cancer Center
              May 21, 2019

              Tumors, Pituitary Tumors Trial in Philadelphia (OTL38)

              Terminated
              • Neoplasms
              • Pituitary Neoplasms
              • Philadelphia, Pennsylvania
                Hospital of the University of Pennsylvania
              Aug 2, 2019

              Pituitary Adenoma Trial (Drug treatment, Surgery)

              Unknown status
              • Pituitary Adenoma
              • Drug treatment
              • Surgery
              • (no location specified)
              Oct 19, 2018

              Pituitary Adenoma Trial in Cardiff (PET imaging)

              Unknown status
              • Pituitary Adenoma
              • PET imaging
              • Cardiff, United Kingdom
                University Hospital of Wales
              Jan 24, 2019

              Invasive Prolactinomas Involving the Cavernous Sinus Trial in China

              Unknown status
              • Invasive Prolactinomas Involving the Cavernous Sinus
                • Beijing, Beijing, China
                • +7 more
                May 15, 2017

                Non-functioning Pituitary Adenomas, Prolactinomas Trial in Rio de Janeiro (Pasireotide, cabergoline)

                Completed
                • Non-functioning Pituitary Adenomas
                • Prolactinomas
                • Rio de Janeiro, RJ, Brazil
                  Endocrinology Section - Hospital Universitário Clementino Fraga
                Jul 21, 2016

                Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (BIIB019 (Daclizumab), trivalent seasonal influenza vaccine)

                Completed
                • Relapsing-Remitting Multiple Sclerosis
                • BIIB019 (Daclizumab)
                • trivalent seasonal influenza vaccine
                • Brno, Czechia
                • +64 more
                Apr 11, 2018